Wooree Bio Co.,Ltd (KOSDAQ: 082850)

Wooree Bio Co.,Ltd Statistics

Total Valuation

Wooree Bio Co.,Ltd has a market cap or net worth of KRW 123.68 billion. The enterprise value is 190.15 billion.

Market Cap	123.68B
Enterprise Value	190.15B

Important Dates

The next estimated earnings date is Monday, March 24, 2025.

Earnings Date	Mar 24, 2025
Ex-Dividend Date	n/a

Share Statistics

Wooree Bio Co.,Ltd has 47.21 million shares outstanding. The number of shares has decreased by -1.24% in one year.

Current Share Class	n/a
Shares Outstanding	47.21M
Shares Change (YoY)	-1.24%
Shares Change (QoQ)	+0.32%
Owned by Insiders (%)	3.68%
Owned by Institutions (%)	7.26%
Float	30.59M

Valuation Ratios

The trailing PE ratio is 14.35.

PE Ratio	14.35
Forward PE	n/a
PS Ratio	0.10
PB Ratio	0.58
P/TBV Ratio	0.59
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 3.65, with an EV/FCF ratio of -7.01.

EV / Earnings	21.95
EV / Sales	0.15
EV / EBITDA	3.65
EV / EBIT	8.09
EV / FCF	-7.01

Financial Position

The company has a current ratio of 1.43, with a Debt / Equity ratio of 0.44.

Current Ratio	1.43
Quick Ratio	1.01
Debt / Equity	0.44
Debt / EBITDA	2.25
Debt / FCF	-4.33
Interest Coverage	4.34

Financial Efficiency

Return on equity (ROE) is 4.76% and return on invested capital (ROIC) is 4.03%.

Return on Equity (ROE)	4.76%
Return on Assets (ROA)	2.23%
Return on Capital (ROIC)	4.03%
Revenue Per Employee	10.03B
Profits Per Employee	68.77M
Employee Count	126
Asset Turnover	1.91
Inventory Turnover	9.90

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +0.19% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+0.19%
50-Day Moving Average	3,215.00
200-Day Moving Average	3,441.33
Relative Strength Index (RSI)	37.10
Average Volume (20 Days)	2,025,369

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Wooree Bio Co.,Ltd had revenue of KRW 1.26 trillion and earned 8.66 billion in profits. Earnings per share was 182.64.

Revenue	1.26T
Gross Profit	123.40B
Operating Income	23.67B
Pretax Income	17.53B
Net Income	8.66B
EBITDA	52.20B
EBIT	23.67B
Earnings Per Share (EPS)	182.64

Balance Sheet

The company has 106.55 billion in cash and 117.41 billion in debt, giving a net cash position of -10.86 billion or -230.11 per share.

Cash & Cash Equivalents	106.55B
Total Debt	117.41B
Net Cash	-10.86B
Net Cash Per Share	-230.11
Equity (Book Value)	268.69B
Book Value Per Share	4,513.88
Working Capital	138.09B

Cash Flow

In the last 12 months, operating cash flow was 49.37 billion and capital expenditures -76.51 billion, giving a free cash flow of -27.14 billion.

Operating Cash Flow	49.37B
Capital Expenditures	-76.51B
Free Cash Flow	-27.14B
FCF Per Share	-574.87

Margins

Gross margin is 9.76%, with operating and profit margins of 1.87% and 0.69%.

Gross Margin	9.76%
Operating Margin	1.87%
Pretax Margin	1.39%
Profit Margin	0.69%
EBITDA Margin	4.13%
EBIT Margin	1.87%
FCF Margin	n/a

Dividends & Yields

Wooree Bio Co.,Ltd does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	1.24%
Shareholder Yield	1.24%
Earnings Yield	6.97%
FCF Yield	-21.94%

Stock Splits

The last stock split was on May 4, 2009. It was a forward split with a ratio of 2.

Last Split Date	May 4, 2009
Split Type	Forward
Split Ratio	2

Scores

Wooree Bio Co.,Ltd has an Altman Z-Score of 2.71. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.71
Piotroski F-Score	n/a